Gregory A. Newby is a scholar working on Molecular Biology, Genetics and Genetics.
According to data from OpenAlex, Gregory A. Newby has authored 59 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 11 papers in Genetics and 6 papers in Genetics. Recurrent topics in Gregory A. Newby's work include CRISPR and Genetic Engineering (40 papers), RNA regulation and disease (14 papers) and Virus-based gene therapy research (10 papers). Gregory A. Newby is often cited by papers focused on CRISPR and Genetic Engineering (40 papers), RNA regulation and disease (14 papers) and Virus-based gene therapy research (10 papers). Gregory A. Newby collaborates with scholars based in United States, Poland and United Kingdom. Gregory A. Newby's co-authors include David R. Liu, Aditya Raguram, Luke W. Koblan, Christopher Wilson, Jonathan M. Levy, Peyton B. Randolph, Peter J. Chen, Andrew V. Anzalone, Jessie R. Davis and Alexander A. Sousa and has published in prestigious journals such as Nature, Science and Cell.
In The Last Decade
Gregory A. Newby
58 papers
receiving
8.5k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Search-and-replace genome editing without double-strand breaks or donor DNA
20192.9k citationsAndrew V. Anzalone, Peyton B. Randolph et al.profile →
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
2018662 citationsLuke W. Koblan, Jordan L. Doman et al.Nature Biotechnologyprofile →
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
2020633 citationsMichelle F. Richter, Kevin T. Zhao et al.Nature Biotechnologyprofile →
Enhanced prime editing systems by manipulating cellular determinants of editing outcomes
2021488 citationsPeter J. Chen, Jeffrey A. Hussmann et al.Cellprofile →
Engineered pegRNAs improve prime editing efficiency
2021463 citationsJames W. Nelson, Peyton B. Randolph et al.Nature Biotechnologyprofile →
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins
2022397 citationsSamagya Banskota, Aditya Raguram et al.Cellprofile →
Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
2020312 citationsJordan L. Doman, Aditya Raguram et al.Nature Biotechnologyprofile →
Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity
2022156 citationsMonica E. Neugebauer, Alvin Hsu et al.Nature Biotechnologyprofile →
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
2024128 citationsMeirui An, Aditya Raguram et al.Nature Biotechnologyprofile →
Efficient prime editing in mouse brain, liver and heart with dual AAVs
2023114 citationsJessie R. Davis, Samagya Banskota et al.Nature Biotechnologyprofile →
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice
2023106 citationsGregory A. Newby, Aditya Raguram et al.profile →
Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice
202385 citationsKelcee A. Everette, Gregory A. Newby et al.Nature Biomedical Engineeringprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Gregory A. Newby
Since
Specialization
Citations
This map shows the geographic impact of Gregory A. Newby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Newby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Newby more than expected).
Fields of papers citing papers by Gregory A. Newby
This network shows the impact of papers produced by Gregory A. Newby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Newby. The network helps show where Gregory A. Newby may publish in the future.
Co-authorship network of co-authors of Gregory A. Newby
This figure shows the co-authorship network connecting the top 25 collaborators of Gregory A. Newby.
A scholar is included among the top collaborators of Gregory A. Newby based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Gregory A. Newby. Gregory A. Newby is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
An, Meirui, Aditya Raguram, Samuel W. Du, et al.. (2024). Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nature Biotechnology. 42(10). 1526–1537.128 indexed citations breakdown →
Davis, Jessie R., Samagya Banskota, Jonathan M. Levy, et al.. (2023). Efficient prime editing in mouse brain, liver and heart with dual AAVs. Nature Biotechnology. 42(2). 253–264.114 indexed citations breakdown →
Everette, Kelcee A., Gregory A. Newby, Rachel M. Levine, et al.. (2023). Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. Nature Biomedical Engineering. 7(5). 616–628.85 indexed citations breakdown →
Neugebauer, Monica E., Alvin Hsu, Mandana Arbab, et al.. (2022). Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. Nature Biotechnology. 41(5). 673–685.156 indexed citations breakdown →
14.
Chen, Peter J., Jeffrey A. Hussmann, Jun Yan, et al.. (2021). Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell. 184(22). 5635–5652.e29.488 indexed citations breakdown →
Nelson, James W., Peyton B. Randolph, Simon P. Shen, et al.. (2021). Engineered pegRNAs improve prime editing efficiency. Nature Biotechnology. 40(3). 402–410.463 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.